Maheshwari Anshul sold $84K of SIBN
Maheshwari Anshul (Chief Op & Financial Officer) sold 3,738 shares of SI-BONE, Inc. (SIBN) at $22.50 on 2026-10-29 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The sale is modest in size and likely to have limited market impact, but it provides a data point for investors monitoring insider activity.
Market read
First‑report insider sale; small amount, limited trading relevance.
What to watch
Potential upcoming corporate actions or earnings that could offset the impact of this small sale.
Background
SEC Form 4 filing discloses an insider transaction by SI‑BONE's CFO.
Ticker impact
Chief Operating & Financial Officer Maheshwari Anshul sold 3,738 shares for $84,105 on Oct 29 via a 10b5‑1 plan.
likely slight downward pressure as the market prices the insider sell.
C‑suite insider sold a modest amount under a pre‑arranged plan; such sales often cause short‑term bearish sentiment.
Market effects
none
none
none
Counterpoint
The sale may be routine under a 10b5‑1 plan and not reflect any negative outlook.
Key entities
- companySI‑BONE, Inc.
Medical device manufacturer listed on NASDAQ under ticker SIBN.
- personMaheshwari Anshul
Chief Operating & Financial Officer of SI‑BONE.
